Identification of a Bidirectional Splicing Enhancer: Differential Involvement of SR Proteins in 5′ or 3′ Splice Site Activation

REFERENCES

• Adams, M. D., D. Z. Rudner, and J. Rio 1996. Biochemistry and regulation of pre-mRNA splicing. Curr. Opin. Cell Biol. 8:331–339.
   PubMedGoogle Scholar
• Berget, S. M. 1995. Exon recognition in vertebrate splicing. J. Biol. Chem. 270:2411–2414.
   PubMed Web of Science ®Google Scholar
• Berk, A. J., and J. Sharp 1978. Structure of the adenovirus 2 early mRNAs. Cell 14:695–711.
   PubMed Web of Science ®Google Scholar
• Black, D. L. 1995. Finding splice sites within a wilderness of RNA. RNA 1:763–771.
   PubMedGoogle Scholar
• Caceres, J. F., S. Stamm, D. M. Helfman, and J. Krainer 1994. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265:1706–1709.
   PubMed Web of Science ®Google Scholar
• Carstens, R. P., W. L. McKeehan, and J. Garcia-Blanco 1998. An intronic sequence element mediates both activation and repression of rat fibroblast growth factor receptor 2 pre-mRNA splicing. Mol. Cell. Biol. 18:2205–2217.
   PubMed Web of Science ®Google Scholar
• Cavaloc, Y., C. F. Bourgeois, L. Kister, and J. Stevenin 1999. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. RNA 5:468–483.
   PubMed Web of Science ®Google Scholar
• Cavaloc, Y., M. Popielarz, J. P. Fuchs, R. Gattoni, and J. Stevenin 1994. Characterization and cloning of the human splicing factor 9G8: a novel 35 kDa factor of the serine/arginine protein family. EMBO J. 13:2639–2649.
   PubMed Web of Science ®Google Scholar
• Chabot, B. 1996. Directing alternative splicing: cast and scenarios. Trends Genet. 12:472–478.
   PubMedGoogle Scholar
• Chan, R. C., and J. Black 1995. Conserved intron elements repress splicing of a neuron-specific c-src exon in vitro. Mol. Cell. Biol. 15:6377–6385.
   PubMed Web of Science ®Google Scholar
• Chandler, S. D., A. Mayeda, J. M. Yeakley, A. R. Krainer, and J. Fu 1997. RNA splicing specificity determined by the coordinated action of RNA recognition motifs in SR proteins. Proc. Natl. Acad. Sci. USA 94:3596–3601.
   PubMedGoogle Scholar
• Chebli, K., R. Gattoni, P. Schmitt, G. Hildwein, and J. Stevenin 1989. The 216-nucleotide intron of the E1A pre-mRNA contains a hairpin structure that permits utilization of unusually distant branch acceptors. Mol. Cell. Biol. 9:4852–4861.
   PubMedGoogle Scholar
• Chow, L. T., T. R. Broker, and J. Lewis 1979. Complex splicing patterns of RNAs from the early regions of adenovirus-2. J. Mol. Biol. 134:265–303.
   PubMed Web of Science ®Google Scholar
• Coulter, L. R., M. A. Landree, and J. Cooper 1997. Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell. Biol. 17:2143–2150.
   PubMed Web of Science ®Google Scholar
• Del Gatto, F., and J. Breathnach 1995. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol. 15:4825–4834.
   PubMedGoogle Scholar
• Dirksen, W. P., R. K. Hampson, Q. Sun, and J. Rottman 1994. A purine-rich exon sequence enhances alternative splicing of bovine growth hormone pre-mRNA. J. Biol. Chem. 269:6431–6436.
   PubMedGoogle Scholar
• Dye, D. T., M. Buvoli, S. A. Mayer, C. H. Lin, and J. Patton 1998. Enhancer elements activate the weak 3′ splice site of alpha-tropomyosin exon 2. RNA 4:1523–1536.
   PubMedGoogle Scholar
• Elrick, L. L., M. B. Humphrey, T. A. Cooper, and J. Berget 1998. A short sequence within two purine-rich enhancers determines 5′ splice site specificity. Mol. Cell. Biol. 18:343–352.
   PubMedGoogle Scholar
• Eperon, I. C., D. C. Ireland, R. A. Smith, A. Mayeda, and J. Krainer 1993. Pathways for selection of 5′ splice sites by U1 snRNPs and SF2/ASF. EMBO J. 12:3607–3617.
   PubMedGoogle Scholar
• Fu, X. D. 1993. Specific commitment of different pre-mRNAs to splicing by single SR proteins. Nature 365:82–85.
   PubMed Web of Science ®Google Scholar
• Fu, X. D. 1995. The superfamily of arginine/serine-rich splicing factors. RNA 1:663–680.
   PubMed Web of Science ®Google Scholar
• Fu, X. D., A. Mayeda, T. Maniatis, and J. Krainer 1992. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc. Natl. Acad. Sci. USA 89:11224–11228.
   PubMed Web of Science ®Google Scholar
• Gallego, M. E., L. Balvay, and J. Brody 1992. cis-Acting sequences involved in exon selection in the chicken β-tropomyosin gene. Mol. Cell. Biol. 12:5415–5425.
   PubMedGoogle Scholar
• Gallego, M. E., R. Gattoni, J. Stevenin, J. Marie, and J. Expert-Bezancon 1997. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A. EMBO J. 16:1772–1784.
   PubMed Web of Science ®Google Scholar
• Gattoni, R., K. Chebli, M. Himmelspach, and J. Stevenin 1991. Modulation of alternative splicing of adenoviral E1A transcripts: factors involved in the early-to-late transition. Genes Dev. 5:1847–1858.
   PubMedGoogle Scholar
• Gattoni, R., P. Schmitt, and J. Stevenin 1988. In vitro splicing of adenovirus E1A transcripts: characterization of novel reactions and of multiple branch points abnormally far from the 3′ splice site. Nucleic Acids Res. 16:2389–2409.
   PubMedGoogle Scholar
• Ge, H., and J. Manley 1990. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62:25–34.
   PubMed Web of Science ®Google Scholar
• Gontarek, R. R., and J. Derse 1996. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing. Mol. Cell. Biol. 16:2325–2331.
   PubMedGoogle Scholar
• Graveley, B. R., K. J. Hertel, and J. Maniatis 1998. A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. EMBO J. 17:6747–6756.
   PubMed Web of Science ®Google Scholar
• Hanamura, A., J. F. Caceres, A. Mayeda, B. R. Franza Jr., and J. Krainer 1998. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4:430–444.
   PubMed Web of Science ®Google Scholar
• Harper, J. E., and J. Manley 1992. Multiple activities of the human splicing factor ASF. Gene Expr. 2:19–29.
   PubMedGoogle Scholar
• Hedley, M. L., and J. Maniatis 1991. Sex-specific splicing and polyadenylation of dsx pre-mRNA requires a sequence that binds specifically to tra-2 protein in vitro. Cell 65:579–586.
   PubMedGoogle Scholar
• Heinrichs, V., and J. Baker 1995. The Drosophila SR protein RBP1 contributes to the regulation of doublesex alternative splicing by recognizing RBP1 RNA target sequences. EMBO J. 14:3987–4000.
   PubMedGoogle Scholar
• Heinrichs, V., L. C. Ryner, and J. Baker 1998. Regulation of sex-specific selection of fruitless 5′ splice sites by transformer and transformer-2. Mol. Cell. Biol. 18:450–458.
   PubMed Web of Science ®Google Scholar
• Hertel, K. J., K. W. Lynch, and J. Maniatis 1997. Common themes in the function of transcription and splicing enhancers. Curr. Opin. Cell Biol. 9:350–357.
   PubMedGoogle Scholar
• Hertel, K. J., and J. Maniatis 1998. The function of multisite splicing enhancers. Mol. Cell 1:449–455.
   PubMed Web of Science ®Google Scholar
• Hibbert, C. S., R. R. Gontarek, and J. Beemon 1999. The role of overlapping U1 and U11 5′ splice site sequences in a negative regulator of splicing. RNA 5:333–343.
   PubMedGoogle Scholar
• Himmelspach, M., Y. Cavaloc, K. Chebli, J. Stevenin, and J. Gattoni 1995. Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing. RNA 1:794–806.
   PubMedGoogle Scholar
• Jamison, S. F., Z. Pasman, J. Wang, C. Will, R. Luhrmann, J. L. Manley, and J. Garcia-Blanco 1995. U1 snRNP-ASF/SF2 interaction and 5′ splice site recognition: characterization of required elements. Nucleic Acids Res. 23:3260–3267.
   PubMed Web of Science ®Google Scholar
• Kanopka, A., O. Muhlemann, and J. Akusjarvi 1996. Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature 381:535–538.
   PubMed Web of Science ®Google Scholar
• Kanopka, A., O. Muhlemann, S. Petersen-Mahrt, C. Estmer, C. Ohrmalm, and J. Akusjarvi 1998. Regulation of adenovirus alternative RNA splicing by dephosphorylation of SR proteins. Nature 393:185–187.
   PubMed Web of Science ®Google Scholar
• Kohtz, J. D., S. F. Jamison, C. L. Will, P. Zuo, R. Luhrmann, M. A. Garcia-Blanco, and J. Manley 1994. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors. Nature 368:119–124.
   PubMed Web of Science ®Google Scholar
• Krainer, A. R., G. C. Conway, and J. Kozak 1990. The essential pre-mRNA splicing factor SF2 influences 5′ splice site selection by activating proximal sites. Cell 62:35–42.
   PubMed Web of Science ®Google Scholar
• Lavigueur, A., H. La Branche, A. R. Kornblihtt, and J. Chabot 1993. A splicing enhancer in the human fibronectin alternate ED1 exon interacts with SR proteins and stimulates U2 snRNP binding. Genes Dev. 7:2405–2417.
   PubMed Web of Science ®Google Scholar
• Lim, L. P., and J. Sharp 1998. Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Mol. Cell. Biol. 18:3900–3906.
   PubMedGoogle Scholar
• Liu, H. X., M. Zhang, and J. Krainer 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev. 12:1998–2012.
   PubMed Web of Science ®Google Scholar
• Lou, H., K. M. Neugebauer, R. F. Gagel, and J. Berget 1998. Regulation of alternative polyadenylation by U1 snRNPs and SRp20. Mol. Cell. Biol. 18:4977–4985.
   PubMed Web of Science ®Google Scholar
• Lynch, K. W., and J. Maniatis 1996. Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev. 10:2089–2101.
   PubMed Web of Science ®Google Scholar
• Manley, J. L., and J. Tacke 1996. SR proteins and splicing control. Genes Dev. 10:1569–1579.
   PubMed Web of Science ®Google Scholar
• Mayeda, A., G. R. Screaton, S. D. Chandler, X. D. Fu, and J. Krainer 1999. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements. Mol. Cell. Biol. 19:1853–1863.
   PubMed Web of Science ®Google Scholar
• McNally, L. M., and J. McNally 1998. An RNA splicing enhancer-like sequence is a component of a splicing inhibitor element from Rous sarcoma virus. Mol. Cell. Biol. 18:3103–3111.
   PubMedGoogle Scholar
• Modafferi, E. F., and J. Black 1997. A complex intronic splicing enhancer from the c-src pre-mRNA activates inclusion of a heterologous exon. Mol. Cell. Biol. 17:6537–6545.
   PubMedGoogle Scholar
• Muro, A. F., A. Iaconcig, and J. Baralle 1998. Regulation of the fibronectin EDA exon alternative splicing. Cooperative role of the exonic enhancer element and the 5′ splice site. FEBS Lett. 437:137–141.
   PubMedGoogle Scholar
• Nagoshi, R. N., and J. Baker 1990. Regulation of sex-specific RNA splicing at the Drosophila doublesex gene: cis-acting mutations in exon sequences alter sex-specific RNA splicing patterns. Genes Dev. 4:89–97.
   PubMedGoogle Scholar
• Popielarz, M., R. Gattoni, and J. Stevenin 1993. Contrasted cis-acting effects of downstream 5′ splice sites on the splicing of a retained intron: the adenoviral E1A pre-mRNA model. Nucleic Acids Res. 21:5144–5151.
   PubMedGoogle Scholar
• Ramchatesingh, J., A. M. Zahler, K. M. Neugebauer, M. B. Roth, and J. Cooper 1995. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol. 15:4898–4907.
   PubMed Web of Science ®Google Scholar
• Robberson, B. L., G. J. Cote, and J. Berget 1990. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 10:84–94.
   PubMed Web of Science ®Google Scholar
• Ryan, K. J., and J. Cooper 1996. Muscle-specific splicing enhancers regulate inclusion of the cardiac troponin T alternative exon in embryonic skeletal muscle. Mol. Cell. Biol. 16:4014–4023.
   PubMed Web of Science ®Google Scholar
• Schaal, T. D., and J. Maniatis 1999. Selection and characterization of pre-mRNA splicing enhancers: identification of novel SR protein-specific enhancer sequences. Mol. Cell. Biol. 19:1705–1719.
   PubMedGoogle Scholar
• Schaal, T. D., and J. Maniatis 1999. Multiple distinct splicing enhancers in the protein-coding sequences of a constitutively spliced pre-mRNA. Mol. Cell. Biol. 19:261–273.
   PubMed Web of Science ®Google Scholar
• Schmitt, P., R. Gattoni, P. Keohavong, and J. Stevenin 1987. Alternative splicing of E1A transcripts of adenovirus requires appropriate ionic conditions in vitro. Cell 50:31–39.
   PubMedGoogle Scholar
• Screaton, G. R., J. F. Caceres, A. Mayeda, M. V. Bell, M. Plebanski, D. G. Jackson, J. I. Bell, and J. Krainer 1995. Identification and characterization of three members of the human SR family of pre-mRNA splicing factors. EMBO J. 14:4336–4349.
   PubMed Web of Science ®Google Scholar
• Selvakumar, M., and J. Helfman 1999. Exonic splicing enhancers contribute to the use of both 3′ and 5′ splice site usage of rat beta-tropomyosin pre-mRNA. RNA 5:378–394.
   PubMedGoogle Scholar
• Si, Z. H., D. Rauch, and J. Stoltzfus 1998. The exon splicing silencer in human immunodeficiency virus type 1 tat exon 3 is bipartite and acts early in spliceosome assembly. Mol. Cell. Biol. 18:5404–5413.
   PubMedGoogle Scholar
• Staffa, A., and J. Cochrane 1995. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell. Biol. 15:4597–4605.
   PubMedGoogle Scholar
• Staknis, D., and J. Reed 1994. SR proteins promote the first specific recognition of pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. Mol. Cell. Biol. 14:7670–7682.
   PubMed Web of Science ®Google Scholar
• Stark, J. M., D. P. Bazett-Jones, M. Herfort, and J. Roth 1998. SR proteins are sufficient for exon bridging across an intron. Proc. Natl. Acad. Sci. USA 95:2163–2168.
   PubMedGoogle Scholar
• Stephens, C., and J. Harlow 1987. Differential splicing yields novel adenovirus 5 E1A mRNAs that encode 30 kd and 35 kd proteins. EMBO J. 6:2027–2035.
   PubMedGoogle Scholar
• Sun, Q., A. Mayeda, R. K. Hampson, A. R. Krainer, and J. Rottman 1993. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer. Genes Dev. 7:2598–2608.
   PubMed Web of Science ®Google Scholar
• Tacke, R., Y. Chen, and J. Manley 1997. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. Proc. Natl. Acad. Sci. USA 94:1148–1153.
   PubMed Web of Science ®Google Scholar
• Tacke, R., and J. Manley 1995. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J. 14:3540–3551.
   PubMed Web of Science ®Google Scholar
• Tacke, R., M. Tohyama, S. Ogawa, and J. Manley 1998. Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell 93:139–148.
   PubMed Web of Science ®Google Scholar
• Tian, H., and J. Kole 1995. Selection of novel exon recognition elements from a pool of random sequences. Mol. Cell. Biol. 15:6291–6298.
   PubMedGoogle Scholar
• Ulfendahl, P. J., S. Linder, J. P. Kreivi, K. Nordqvist, C. Sevensson, H. Hultberg, and J. Akusjarvi 1987. A novel adenovirus-2 E1A mRNA encoding a protein with transcription activation properties. EMBO J. 6:2037–2044.
   PubMedGoogle Scholar
• Wang, J., and J. Manley 1995. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335–346.
   PubMed Web of Science ®Google Scholar
• Wang, J., S. H. Xiao, and J. Manley 1998. Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing. Genes Dev. 12:2222–2233.
   PubMedGoogle Scholar
• Wang, Z., H. M. Hoffmann, and J. Grabowski 1995. Intrinsic U2AF binding is modulated by exon enhancer signals in parallel with changes in splicing activity. RNA 1:21–35.
   PubMed Web of Science ®Google Scholar
• Watakabe, A., K. Tanaka, and J. Shimura 1993. The role of exon sequences in splice site selection. Genes Dev. 7:407–418.
   PubMed Web of Science ®Google Scholar
• Wu, J. Y., and J. Maniatis 1993. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing. Cell 75:1061–1070.
   PubMed Web of Science ®Google Scholar
• Xiao, J. H., I. Davidson, H. Matthes, J. M. Garnier, and J. Chambon 1991. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell 65:551–568.
   PubMed Web of Science ®Google Scholar
• Xu, R., J. Teng, and J. Cooper 1993. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element. Mol. Cell. Biol. 13:3660–3674.
   PubMedGoogle Scholar
• Zahler, A. M., K. M. Neugebauer, W. S. Lane, and J. Roth 1993. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science 260:219–222.
   PubMed Web of Science ®Google Scholar
• Zahler, A. M., and J. Roth 1995. Distinct functions of SR proteins in recruitment of U1 small nuclear ribonucleoprotein to alternative 5′ splice sites. Proc. Natl. Acad. Sci. USA 92:2642–2646.
   PubMed Web of Science ®Google Scholar
• Zhang, W. J., and J. Wu 1996. Functional properties of p54, a novel SR protein active in constitutive and alternative splicing. Mol. Cell. Biol. 16:5400–5408.
   PubMed Web of Science ®Google Scholar
• Zuo, P., and J. Manley 1994. The human splicing factor ASF/SF2 can specifically recognize pre-mRNA 5′ splice sites. Proc. Natl. Acad. Sci. USA 91:3363–3367.
   PubMedGoogle Scholar